Serum markers of oxidative stress and severity of diabetic retinopathy

Diabetes Care

Volumn 23, Issue 2, 2000, Pages 234-240

  Hartnett, M Elizabeth ^b,d   Stratton, Robert D ^c   Browne, Richard W ^b   Rosner, Bernard A ^a   Lanham, Richard J ^b   Armstrong, Donald ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c Erie Retinal Surgery   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATININE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN A1C; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETIC RETINOPATHY; DISEASE SEVERITY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOSCOPY; OXIDATIVE STRESS; VISUAL ACUITY;

EID: 0033979291     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.2.234     Document Type: Article

References (47)

1. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-411, 1991
2. Wolff S: The potential role of oxidation and its complications: novel implications for theory and therapy. In The Diabetec Complications: Scientific and Clinical Aspects. McCrabbe JC, Ed. London, Churchill-Livingstone, 1987, p. 167-220
3. Van den Enden MK, Nyengaard IR, Ostrow E, Burgan JH, Williamson JR: Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism: implications for diabetic retinopathy. Invest Ophthalmol Vis Sci 36:1675-1685, 1995
4. Ruggiero D, Lecomte M, Michoud E, Lagarde M, Wiernsperger N: Involvement of cell-cell interactions in the pathogenesis of diabetic retinopathy. Diabetes Metab 23: 30-42, 1997
5. Armstrong D, Ueda T, Aljada A, Browne R, Fukuda S, Spengler R, Chou R, Hartnett M, Buch P, Dandona P, Sasisekharan R, Dorey CK: Lipid hydroperoxide stimulates retinal neovascularization in rabbit retina through expression of tumor necrosis factor-alpha, vascular endothelial growth factor and platelet-derived growth factor. Angiogenesis 2:93-104, 1998
6. Dorey CK, Aouididi S, Reynaud X, Dvorak HE, Brown LF: Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat. Arch Ophthalmol 114:1210-1217, 1996
7. (erratum in Arch Ophthalmol 115:192, 1997)
8. Clermont AC, Aiello LP, Aiello LM, Schlossman D, Kopple A, King GL, Burcell SE: Vitamin E normalized retinal blood flow in diabetic patients with minimal diabetic retinopathy: results of a double masked crossover clinical trial (Abstract). Invest Ophthalmol Vis Sci 39 (Suppl. 4):S1000, 1998
9. Miller JW, Adamis AP, Shima DT, D'Amore PA, Moulton RS, O'Reilly MS, Folkman J, Dvorak HF, Brown LF, Berse B, Yeo I, Yeo K: Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 145:574-584, 1994
10. Adamis AP, Miller JW, Bernal MT, D'Amico DJ, Folkman J, Yeo TK, Yeo KT: Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118: 445-450, 1994
11. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HP, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331: 1480-1487, 1994
12. Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA: Hypoxic regulation of vascular endothelial growth factor in retinal cells. Archi Ophthalmol 113:1538-1544, 1995
13. Segawa Y, Shirao Y, Yamagishi S, Higashide T, Kobayashi M, Katsuno K, Iyobe A, Harada H, Sato F, Miyata H, Asai H, Nishimura A, Takahira M, Souno T, Segawa Y, Maeda K, Shima K, Mizuno A, Yamamoto H, Kawasaki K: Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. Ophthalmoic Res 30:333-339, 1998
14. Lu M, Kuroki M, Amano S, Tolentino M, Keough K, Kim I, Bucala R, Adamis AP: Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest 101:1219-1224, 1998
15. Kuroki M, Voest EE, Amano S, Beerepoot LV, Takashima S, Tolentino M, Kim RY, Rohan RM, Colby KA, Yeo KT, Adamis AP: Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest 98:1667-1675, 1996
16. Diabetes Control and Complications Trial Research Group: The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophthalmol 113:36-51, 1995
17. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, Van den Enden M, Kilo C, Tilton RG: Hyperglycemic pseudohypoxia and diabetic complications (Perspectives in Diabetes). Diabetes 42:801-813, 1993
18. Nishigaki I, Hagihara M, Tsunekawa H, Maseki M, Yagi K: Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem Med 25:373-378, 1981
19. Armstrong P, Abdella N, Salman A, Miller N, Rahman EA, Bojancyzk M: Relationship of lipid peroxides to diabetic complications: comparison with conventional laboratory tests. J Diabetes Complications 6:116-122, 1992
20. Peuchant E, Delmas-Beauvieux MC, Couchouron A, Dubourg L, Thomas MJ, Perromat A, Clere M, Gin H Short-term insulin therapy and normoglycemia: effects on erythrocyte lipid peroxidation in NIDDM patients. Diabetes Care 20:202-207, 1997
21. Akkus I, Kalak S, Vural H, Caglayan O, Menekse E, Can G, Durmus B: Leukocyte lipid peroxidation, superoxide dismutase, glutahione peroxidase, and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus. Clin Chim Acta 244:221-227, 1996
22. Losada M, Alio JL: Malondialdehyde serum concentration in type 1 diabetics with and without retinopathy. Doc Ophthalmol 93: 225-229, 1996
23. Santini SA, Marra G, Giardina B, Cotroneo P, Mordente A, Martorana GE, Manto A, Ghirlanda G: Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes 46:1853-1858, 1997
24. Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knoebl P, Pietschmann P, Prager R, Schnack C, Schernthaner G, Mueller M: Enhanced serum levels of thiobarbituric acid-reactive substances in diabetes mellitus. Am J Med 98: 469-475, 1995
25. Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group: Manual of Operations. Baltimore, MD, ETDRS Coordinating Center, University of Maryland, 1980. Available from National Technical Information Service, 5285 Port Royal Rd., Springfield, VA 22161 (accession no. PB85 225006/AS)
26. Ferris EL 3rd, Bailey I: Standardizing the measurement of visual acuity for clinical research studies: guidelines from the Eye Care Technology Forum. Ophthalmology 105:181-182, 1996
27. Diabetic Retinopathy Study Research Group: Report 7: a modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 21:210-226, 1981
28. Early Treatment Diabetic Retinopathy Study Research Group: Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics: ETDRS report number 7. Ophthalmology 98 (Suppl. 5):741-756, 1991
29. Early Treatment Diabetic Retinopathy Study Research Group: Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS report number 12. Ophthalmology 98 (Suppl. 5):823-833, 1991
30. Early Treatment Diabetic Retinopathy Study Research Group: Photocoagulation for diabetic macular edema: ETDRS report number 1. Arch Ophthalmol 103:1796-1806, 1985
31. Armstrong D, Browne R: The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. Adv Exp Med Biol 366:43-58, 1994
32. Ookawara T, Kawamura N, Kitagawa Y, Tamguchi N: Site-specific and random fragmentation of Cu,Zn-superoxide dismutase by glycation reaction: implication of reactive oxygen species. J Biol Chem 267: 18505-18510, 1992
33. Arai K, Iizuka S, Tada Y, Oikawa K, Tamguchi N: Increase in the glucosylated form of erythrocyte Cu-Zn-superoxide dismutase in diabetes and close association of the nonenzymatic glucosylation with the enzyme activity. Biochim Biophys Acta 924:292-296, 1987
34. Abdella N, Al Awadi F, Salman A, Armstrong D: Thiobarbituric acid test as a measure of lipid peroxidation in Arab patients with NIDDM. Diabetes 15:173-177, 1990
35. Girelli D, Olivieri O, Stanzial AM, Guarini P, Trevisan MT, Bassi A, Corrocher R: Factors affecting the thiobarbituric acid test as index of red blood cell susceptibility to lipid peroxidation: a multivariate analysis. Clin Chim Acta 227:45-57, 1994
36. Browne R, Armstrong D: Separation of hydroxy and hydroperoxy polyunsaturated fatty acids by high-pressure liquid chromatography. In Free Radical and Antioxidant Protocols. Armstrong D, Ed. Totowa, NJ, Humana, 1998, p. 147-155
37. Lu D, Maulik K, Moraru II, Kreutzer DL, Das DK: Molecular adaptation of vascular endothelial cells to oxidative stress. Am J Physiol 264:C715-C722, 1993
38. Rema M, Mohan V, Bhaskar A, Shanmugasundaram KR: Does oxidant stress play a role in diabetic retinopathy? Indian J Ophthalmol 43:17-21, 1995
39. Vuciíc M, Gavella M, Bozikov V, Ashcroft SJ, Rocic B: Superoxide dismutase activity in lymphocytes and polymorphonuclear cells of diabetic patients. European J Clin Chem Biochem 35:517-521, 1997
40. Walter RM, Uriu-Hare JY, Olin KL, Oster MH, Anawalt BD, Critchfield JW, Keen CL: Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus. Diabetes Care 14:1050-1056, 1991
41. Kedziora-Kornatowska KZ, Luciak M, Blaszczyk J, Pawlak W: Lipid peroxidation and activities of antioxidant enzymes in erythrocytes of patients with non-insulin dependent diabetes with or without diabetic nephropathy. Nephrol Dial Transplant 13:2829-2832, 1998
42. Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, Chew EY, Ferris FL, Knatterud GL, for the Early Treatment Diabetic Retinopathy Study Research Group: Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci 39: 233-252, 1998
43. Moss SE, Klein R, Klein BE: Ten-year incidence of visual loss in a diabetic population. Ophthalmology 101:1061-1070, 1994
44. Klein BE, Klein R, Lee KE: Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. Am J Ophthalmol 126:782-790, 1998
45. Yamamolo S, Kamiyama M, Nitta K, Yamada T, Hayasaka S: Selective reduction of the S cone electroretinogram in diabetes. Br J Ophthalmol 80:973-975, 1996
46. Yamamoto S, Takeuchi S, Kamiyama M: The short wavelength-sensitive cone electroretinogram in diabetes: relationship to systemic factors. Doc Ophthalmol 94:193-200, 1997-1998
47. Arend O, Remky A, Evans D, Stuber R, Harris A: Contrast sensitivity loss is coupled with capillary dropout in patients with diabetes. Invest Ophthalmol Vis Sci 38:1819-1824, 1997